Deintensifying Diabetes Management for Older Adults Living in Long-Term Care
Over 25% of older adults living in long-term care (LTC) have diabetes. In Ontario, more than half of LTC residents with diabetes are treated too strictly (i.e. A1c < 7%). This puts residents at risk for harms like low blood sugar and its consequences (e.g., falls,...
Betty Havens Prize for Knowledge Translation in Aging
Dr. Barbara Farrell and the Deprescribing.org Research Team received the 2019 Betty Havens Prize for Knowledge Translation Aging for outstanding achievements related to the spread and uptake of their deprescribing guidelines. Since 2013, the team has worked tirelessly...
Deprescribing in Ontario Long-term Care Framework
Deprescribing in Ontario Long-term Care Framework In Canada, older adults living in long-term care (LTC) homes experience polypharmacy at higher rates than their community-living counterparts and strategies to reduce polypharmacy are urgently needed. This research...
Evaluation of a Deprescribing Guideline Mobile Application
The four evidence-based deprescribing guidelines and algorithms produced through the leadership of Deprescribing.org and the Ontario Pharmacy Evidence Network and the guideline developed through an NHMRC-ARC Dementia Research Fellowship have been built as a series of...
Acetylcholinesterase inhibitors and memantine deprescribing guideline
Using the evidence-based deprescribing guideline method established by deprescribing.org, Dr. Reeve developed an Australian/Canadian-focused prescribing guideline for acetylcholinesterase inhibitors and memantine. The next steps include an evaluation of the...
Building Capacity for Deprescribing Guideline Development, Implementation, and Evaluation
This knowledge mobilization grant supported a variety of strategies designed to help healthcare providers and members of the public use deprescribing guidelines effectively. These included whiteboard training videos, mobile apps, webinars, a wide-reaching social media...